Kennametal (KMT) Upgraded to Buy: Here's Why — Positive
KMT Zacks Investment Research — July 21, 2025Kennametal (KMT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

atai Life Sciences (ATAI) Upgraded to Strong Buy: Here's Why — Positive
ATAI Zacks Investment Research — July 21, 2025atai Life Sciences (ATAI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Applied Materials (AMAT) Upgraded to Buy: Here's What You Should Know — Positive
AMAT Zacks Investment Research — July 21, 2025Applied Materials (AMAT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Triple Flag (TFPM) Upgraded to Buy: What Does It Mean for the Stock? — Positive
TFPM Zacks Investment Research — July 21, 2025Triple Flag (TFPM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

All You Need to Know About Century Therapeutics (IPSC) Rating Upgrade to Strong Buy — Positive
IPSC Zacks Investment Research — July 21, 2025Century Therapeutics (IPSC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Are You Looking for a Top Momentum Pick? Why Acadian Asset Management (AAMI) is a Great Choice — Positive
AAMI Zacks Investment Research — July 21, 2025Does Acadian Asset Management (AAMI) have what it takes to be a top stock pick for momentum investors? Let's find out.

Bank7 (BSVN) Upgraded to Buy: Here's What You Should Know — Positive
BSVN Zacks Investment Research — July 21, 2025Bank7 (BSVN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

CNBC's Steve Kovach with the latest details on Apple's plan for a foldable iPhone.

Sticky Inflation Is Back In Focus: Time To Consider High Yields — Neutral
ARCC BIZD BX BXSL JPM MAIN O VZ WFC XLRE Seeking Alpha — July 21, 2025With inflation sticky and rate cuts unlikely in 2024, investors should consider repositioning into high-yield stocks to offset volatility. Ares Capital (ARCC) and Blackstone Secured Lending (BXSL) offer strong fundamentals, high yields, and benefit from higher-for-longer interest rates. Verizon (VZ) and Realty Income (O) provide attractive yields and blue-chip stability, despite near-term headwinds from elevated rates.

Marriott International: A Wonderful Company At A Fair Price — Positive
MAR Seeking Alpha — July 21, 2025Marriott International is a high-quality, industry-leading hotel group trading at a fair price, making it an attractive investment opportunity. The company has significantly outperformed the S&P 500 over the past decade, despite not being in the tech sector. Marriott's capital-light business model, focused on franchise and management fees, drives strong returns and reduces risk.

A. O. Smith Set to Report Q2 Earnings: Is a Beat in Store? — Neutral
AOS Zacks Investment Research — July 21, 2025AOS eyes an earnings beat in Q2 2025, backed by boiler demand and water treatment growth despite global headwinds.

DocuSign's IAM: Automating Agreements, Redefining Enterprise — Positive
DOCU Zacks Investment Research — July 21, 2025DOCU's AI-powered IAM platform is transforming agreement workflows through deep Microsoft and Salesforce integrations.

The CEO also announced he would buy up to $10 million worth of stock over the next 12 months.

Can Tesla's Energy & Services Units Aid Its Earnings This Season? — Positive
TSLA Zacks Investment Research — July 21, 2025TSLA's Q2 may get a lift from surging energy deployments and rising service profits as EV sales falter.

Otis Worldwide to Report Q2 Earnings: Here's What Investors Must Know — Neutral
OTIS Zacks Investment Research — July 21, 2025OTIS eyes Q2 sales growth on strong service demand, but inflation and weak new equipment volumes are likely to have weighed on margins.

Is StoneCo's 2027 TPV Target Achievable Amid Rising Competition? — Positive
STNE Zacks Investment Research — July 21, 2025STNE targets R$670B MSMB TPV by 2027, banking on cross-sell strength and PIX adoption amid stiff market competition.

Stride Stock Tumbles 9% in Past Month: Should You Buy the Dip or Wait? — Negative
LRN Zacks Investment Research — July 21, 2025LRN's stock slides 9% on a key contract loss, but 20% enrollment growth and strong fundamentals may hint at long-term upside.

Buy, Sell or Hold ServiceNow Stock? Key Tips Ahead of Q2 Earnings — Negative
NOW Zacks Investment Research — July 21, 2025Although NOW's strong portfolio and rich partner base are noteworthy, tariffs and stretched valuation are major concerns ahead of Q2 earnings.

Will Strategic Use of ADESA Infrastructure Support Carvana's Goal? — Neutral
CVNA Zacks Investment Research — July 21, 2025CVNA is leveraging ADESA's infrastructure and underused assets to scale operations toward its 3 million car sales goal.

Zimmer Biomet Q2 Preview: Combining Monogram Autonomous Robotics With ROSA — Positive
ZBH Seeking Alpha — July 21, 2025I reiterate my Buy rating on Zimmer Biomet Holdings, Inc., setting a fair value of $133 per ZBH share due to strong business acceleration opportunities. The Monogram Technologies acquisition could significantly enhance Zimmer's knee robotics, positioning it to better compete with Stryker through advanced autonomous technology. Paragon 28's integration is on track and expected to boost Zimmer's foot and ankle portfolio, contributing to topline growth in a fast-expanding market.
